logo_web
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet
✕
  • Clinical Trials
    • Management of medication
    • Management of reimbursement of expenses to patients
    • Supply of medical devices
    • Destruction
    • Calibration of medical devices
    • Import and labeling of medication
    • Masking. Placebos manufacturing
  • Blog
  • Quality
    • Certifications
    • RSE
  • Clients
  • Patient Reimbursement Forms
    • Validation / Expense Reimbursement Sheet

CNIO, scientific leadership in oncology research

Source: www.immedicohospitalario.es

It is among the top 10 cancer research centres in the world and among the top two in Europe. Since its creation in 1998, the Spanish National Cancer Research Centre (CNIO) has generated a legacy of research excellence, always with the aim of offering high-level scientific work and innovative technology, as well as being able to transfer the results of its research to cancer patients.

At the CNIO, all aspects related to cancer are investigated and new fields of cancer research are sought together with therapeutic strategies and drugs against this pathology. Innovation has become one of its priorities, generating patents, collaborating with industry and creating spin-off companies, as well as offering services to other scientists and support in the diagnosis and prognosis of oncological diseases.

Likewise, leadership in patient-oriented research, scientific production, exploitation and transfer of research results, and attracting talent, are other of its main lines of action.

The Centro Nacional de Investigaciones Oncológicas was created in 1998 by the Instituto de Salud Carlos III with the mission of developing a comprehensive project of excellence in cancer research. It is currently attached to the Ministry of Science and Innovation.

Since 2003, the CNIO headquarters have been located on the Chamartín campus of the Carlos III Health Institute in Madrid, when the building was inaugurated. It has 32,000m² of space and 10,000m² of laboratories dedicated to oncology research and a 3,000m² SPF animal facility. The Centre consists of two distinct parts: the former Victoria Eugenia hospital, which was refurbished, houses the basic research laboratories, library and offices, and another annex building houses all the applied research laboratories and the animal facility, one of the largest in Europe, equipped with robotic washing systems to guarantee homogeneous and standardised treatment of the processes.

Its management is coordinated by the Carlos III National Cancer Research Centre Foundation, which was created at the same time as the centre itself. This Foundation is the owner of the rights, obligations and assets of the CNIO, and its purpose is to promote cancer research through the Centre, which carries out the scientific activity. Thus, its management system combines business flexibility with the accounting rigour inherent to the state ownership of the Foundation and the system of control and justification of the public funds received.

Moreover, it should be noted that the CNIO is one of the six Spanish research centres that have received governmental accreditation as a Severo Ochoa Centre of Excellence continuously since the creation of this programme in 2011, which was renewed in 2020 for four more years.

Areas of work

The CNIO currently hosts 26 Research Groups-Clinical Research Units, 17 Section Units, distributed in six Research Programmes, divided into three areas: basic research; patient-oriented research; and innovation.

These areas cover multiple aspects and approaches related to cancer research, from the study of the basic molecular mechanisms involved in cellular malignancy to the development of therapeutic and diagnostic strategies useful for patients.

The Basic Research area includes the Molecular Oncology Programme and the Structural Biology Programme. The Patient-Oriented Research area contains the Human Cancer Genetics Programme and the Clinical Research Programme. The Innovation area includes the Biotechnology Programme, the Experimental Therapies Programme, and the Technology Transfer Office.

The Basic Research and Patient-Oriented Research Programmes are in charge of scientific progress in cancer research, with the latter also responsible for the application of this knowledge to the clinical development of new therapeutic strategies.

The Innovation area integrates all the Innovation activities of the CNIO Scientific Programmes through the Technology Transfer Office, as well as the Support Units of the Biotechnology Programme, which provide state-of-the-art services and technologies, and the Experimental Therapeutics Programme, which has all the capabilities to address the early stages of the drug discovery and development process.

There is also a Biobank, registered in the National Biobank Register of the Carlos III Health Institute, whose mission is to obtain, process, store and share biological samples of human origin for research excellence in cancer and related processes, in line with the highest technical, ethical and quality standards, as well as providing support to all areas.

Promoting the participation and coordination of European and international consortiums and networks by the centre’s researchers, establishing alliances with other institutions of international prestige and strengthening the incorporation of talent from outside Spain (8% of the staff is foreign, and 12% in the case of trainees), is part of the CNIO’s current strategy, which also aspires to achieve the HR Excellence in Research Award accreditation issued by the European Commission to recognise institutions that make progress in aligning their human resources policies.

No gender barriers

Another of the characteristics of the CNIO’s staff, made up of more than 500 researchers, is that it is mainly made up of women, 68% of the total number of scientists.

To fight against gender stereotypes and promote awareness of the need for actions aimed at achieving and ensuring gender equality in science, the Centre has had a CNIO Women and Science Office (WISE Office) since 2012, whose objectives include helping to correct any imbalances that may exist in its staff, as well as supporting women researchers in achieving their goals.

This work was reinforced from 2019 with the establishment of an Equality Plan that compiles a set of measures and actions that ensure the principle of equality between women and men at the Centre.

Its aim, in addition to avoiding any kind of discrimination in the workplace, is to guarantee and promote real and effective equal opportunities among its employees. The CNIO Director also refers to this Plan in her interview with ‘IM Médico’.

 

 

Related entries

13 May, 2025

Farmaindustria presents improvements to the Medicines Bill to prepare healthcare for innovation over the next 20 years


Leer más
12 May, 2025

Fina Lladós: ‘We have before us a unique opportunity in these legislative developments to transform our healthcare and prepare it for the next 20 years’.


Leer más
8 May, 2025

Spain, a European success story in clinical trials of new drugs


Leer más

Recent Posts

  • Farmaindustria presents improvements to the Medicines Bill to prepare healthcare for innovation over the next 20 years
  • Fina Lladós: ‘We have before us a unique opportunity in these legislative developments to transform our healthcare and prepare it for the next 20 years’.
  • Spain, a European success story in clinical trials of new drugs
  • Joint position on the draft Medicines and Medical Devices Law
  • The global pharmaceutical industry had 12,700 drugs in development by 2024

Contacta con nosotros


Tfno: +34 955.77.67.67
Fax: +34 955.77.65.56
info@distefar.net


Distefar del Sur
Sede Central

Distefar del Sur S.L.
Av. Umbrete, 58,
41110 Bollullos de la Mitación, Sevilla

Sede Madrid

Calle de Zurbano, 45, 28010 Madrid

CENTRAL

Pol. PIBO. Avda. de Gines, 14
+34 955 776 767 /+34 692 454 913
41110 Bollullos de la Mitación (Sevilla)

MADRID DELEGATION

+34 674 575 115
28010 Madrid

Links of interest

  • Legal warning
  • Privacy policy
  • Cookies policy
  • Contact

© 2025 Distefar del Sur SL. All rights reserved. agencianodo.com

  • Contact
  • Private Zone
  • Español
  • English

    [recaptcha]

    In accordance with the provisions of Regulation (EU) 2016/679 and Organic Law 3/2018 regarding Data Protection, we inform you that the data you provide in this form will be incorporated into a file owned by DISTEFAR DEL SUR, SL domiciled in the C / Umbrete 58, (Pol. Ind. Pibo), 41110 of Bollullos de la Mitación (Seville), in order to manage your request.

    In this regard, and if you wish to exercise your rights of access, rectification, cancellation, opposition, portability and limitation, please send a written communication to DISTEFAR DEL SUR, SL, to the address indicated above or to info@distefar.com, attaching copy of your National Identity Document or equivalent identification document.

    Basic information about Data Protection

     Epigraph

    Basic information Data Protection

    Responsable

    DISTEFAR DEL SUR, S.L.

    Purpose

    Process your inquiry / request
    Detailed information on Data Protection

    Legitimation

    Consent
    Detailed information on Data Protection

    Recipients

    It is not expected to carry out data communications to third parties, except legal obligation
    Transfers of data to third countries outside the European Union will not be carried out
    Detailed information on Data Protection

    Rights

    You have the right of access, rectification, deletion, portability of your data, as well as limitation or opposition to your treatment, as detailed in Detailed information on Data Protection

    Additional Information

    You can consult the additional and detailed information on data protection by clicking here Detailed information on Data Protection

    All the data requested / The fields marked with * in the form are mandatory, if not filled in DISTEFAR DEL SUR, S.L. will not be able to meet your request.